FANCONI ANEMIA, COMPLEMENTATION GROUP D1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
37
|
0.920 |
definitive |
1.000 |
17 |
37
|
2002 |
2018 |
BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
phenotype |
|
Finding
|
1
|
|
0.300 |
definitive |
1.000 |
10 |
|
1996 |
2017 |
OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
phenotype |
|
Finding
|
1
|
|
0.300 |
definitive |
1.000 |
10 |
|
1996 |
2017 |
GLIOMA SUSCEPTIBILITY 3
|
disease |
|
Finding
|
1
|
22
|
0.400 |
strong |
1.000 |
2 |
22
|
2007 |
2013 |
PANCREATIC CANCER, SUSCEPTIBILITY TO, 2
|
disease |
|
Finding
|
1
|
21
|
0.400 |
strong |
1.000 |
2 |
21
|
2007 |
2013 |
Glial tumor of brain (disorder)
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
BRCA1 Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
hereditary breast/ovarian cancer - BRCA1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Thyroid papillary adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
disease |
|
Finding
|
2
|
2633
|
0.700 |
definitive |
1.000 |
407 |
2632
|
1988 |
2019 |
Ovarian Serous Surface Papillary Adenocarcinoma
|
disease |
|
Neoplastic Process
|
2
|
2
|
0.100 |
None |
1.000 |
2 |
1
|
2006 |
2009 |
Fallopian Tube Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Residual ovary syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Primary serous papillary carcinoma of peritoneum
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Contralateral Breast Carcinoma
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Usual ductal hyperplasia of breast
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neuroendocrine tumor of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2004 |
2004 |
Hereditary site-specific ovarian cancer syndrome
|
disease |
|
Disease or Syndrome
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Childhood Ovarian Germ Cell Tumor
|
disease |
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
stage IV pancreatic cancer
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Atypical medullary carcinoma
|
disease |
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
3
|
2277
|
0.100 |
None |
|
0 |
18
|
|
|
Pelvic Cancer
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
FANCONI ANEMIA, COMPLEMENTATION GROUP N
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
4
|
13
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Undifferentiated carcinoma of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |